Q32 Bio to Participate in the 2025 Wells Fargo Healthcare Conference

WALTHAM, Mass., Aug. 28, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced that management will participate in a fireside chat at 3:45 p.m. E.T. on Thursday, September 4^th at the 2025 Wells Fargo Healthcare Conference.

Read more at prnewswire.com